2Suppliers
12Customers
3Debt Items
20Related Chains

Source-Backed Evidence Depth

Adagio Medical Holdings, Inc. (ADGM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships
2Distinct source URLs
6High confidence
0.724Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Adagio Medical Holdings, Inc. Suppliers

TickerNameConfidenceEvidence
FIVE-AND-TEN-LARGEST-SUPPLIERS FIVE-AND-TEN-LARGEST-SUPPLIERS 90% The Company’s five and ten largest suppliers accounted for approximately 30 % and 43 %, respectively, of the Company’s expenditures for the three months ended March 31, 2025.
THREE-SUPPLIERS THREE-SUPPLIERS 90% The Company had three suppliers exceed 10% of total accounts payable as of December 31, 2025, representing 74 % of accounts payable.

Adagio Medical Holdings, Inc. Customers

TickerNameConfidenceEvidence
JNJ Johnson & Johnson 72% an 1% of energy applications accompanied by observations of microbubbles or faint muscle contractions. The pre-clinical investigation of ventricular PFCA in the animal model demonstrated lesion depth…
JNJ Johnson & Johnson 72% Reciprocal relationship from JNJ graph: Reciprocal relationship from ADGM graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from ADGM graph: an 1% of energy applications accompan…
ADAGIO-MEDICAL-GMBH ADAGIO-MEDICAL-GMBH 62% occurrence of a triggering event, an entity has the option to first assess qualitative factors to determine whether a quantitative impairment test is necessary. If it is more likely than not that goo…
ADAGIO-MEDICAL-INC ADAGIO-MEDICAL-INC 62% be wrong, and we could exhaust our capital resources sooner than expected. No assurance can be given as to whether additional needed financing will be available on terms acceptable to us, if at all. …
AJA-HOLDCO-INC AJA-HOLDCO-INC 62% ve proposals to further reform healthcare or reduce healthcare costs may limit coverage of or lower reimbursement for the procedures associated with the use of our products. For example, on July 4, 2…
ARYA-SCIENCES-ACQUISITION-CORP ARYA-SCIENCES-ACQUISITION-CORP 62% be wrong, and we could exhaust our capital resources sooner than expected. No assurance can be given as to whether additional needed financing will be available on terms acceptable to us, if at all. …
BIOSENSE-WEBSTER-INC BIOSENSE-WEBSTER-INC 62% an 1% of energy applications accompanied by observations of microbubbles or faint muscle contractions. The pre-clinical investigation of ventricular PFCA in the animal model demonstrated lesion depth…
CORPORATE-INFORMATION-ADAGIO-MEDICAL-HOLDINGS-IN CORPORATE-INFORMATION-ADAGIO-MEDICAL-HOLDINGS-IN 62% ve proposals to further reform healthcare or reduce healthcare costs may limit coverage of or lower reimbursement for the procedures associated with the use of our products. For example, on July 4, 2…
EMERGING-GROWTH-COMPANY EMERGING-GROWTH-COMPANY 62% od and Drug Administration (“FDA”) for the Company’s vCLAS™ Ventricular Ablation System for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia in patients with…
PERCEPTIVE-ADVISORS-LLC PERCEPTIVE-ADVISORS-LLC 62% (collectively, “Legacy Adagio Convertible Notes”), at fair value at issuance and subsequently remeasure them to fair value at each reporting period. The change in fair value of the Convertible Securi…
PERCEPTIVE-LIFE-SCIENCES-MASTER-FUND-LTD PERCEPTIVE-LIFE-SCIENCES-MASTER-FUND-LTD 62% ilities fair value adjustment ​ ​ (131) ​ ​ 38 ​ ​ (169) ​ ​ (445) ​ Interest expense ​ ​ (778) ​ ​ (662) ​ ​ (116) ​ ​ 18 ​ Interest income ​ ​ 107 ​ ​ 164 ​ ​ (57) ​ ​ (35) ​ Other income (expense)…
PRODUCT-SERVICE-GMBH PRODUCT-SERVICE-GMBH 62% ve proposals to further reform healthcare or reduce healthcare costs may limit coverage of or lower reimbursement for the procedures associated with the use of our products. For example, on July 4, 2…

Adagio Medical Holdings, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ADGM-DEBT-7508 Xbrl Convertible 90% xbrl convertible detail from xbrl 2026-03-31.
ADGM-DEBT Debt stack $24.8M 90% Market cache reports total debt of $24.8M.
ADGM-DEBT-7507 Warrants outstanding: 4332000 90% xbrl warrant detail from xbrl 2025-12-31.

Adagio Medical Holdings, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Adagio Medical Holdings, Inc..

Adagio Medical Holdings, Inc. Ownership

HolderNameConfidenceEvidence
ADGM-OWNER-PERCEPTIVE-ADVISORS-LLC PERCEPTIVE ADVISORS LLC 90% 13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 24 tracked holders.

Adagio Medical Holdings, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ACIU AC Immune SA 100.00 2
CRIS Curis, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
ABBV AbbVie Inc. 100.00 2
ATON AlphaTON Capital Corp 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
AURA Aura Biosciences, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2
AORT Artivion, Inc. 100.00 2
SNNUF Smith & Nephew plc 100.00 2
ALC Alcon Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
HCWB HCW Biologics Inc. 100.00 2
🔐
ADGM
Unlock ADGM Supply Chain Data
Verified relationships include:
FIVE-AND-TEN-LARGEST-SUPPLIERSFIVE-AND-TEN-LARGEST-SUPPLIERSSupplier90%
THREE-SUPPLIERSTHREE-SUPPLIERSSupplier90%
JNJJohnson & JohnsonCustomer72%
JNJJohnson & JohnsonCustomer72%
+14 more relationships locked
Subscribe — View plans →